Since the start of 2024, Wockhardt’s stock price has almost tripled to Rs 1,233.85 per share as on November 8.

Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery - Observed weight loss was 17% at 28 days, a 25% ...

2. Ultra-long-acting insulin: Smoother insulin release, reduced peaks. 3. Inhaled insulin: Convenient, rapid-acting insulin ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Insulet Co. (NASDAQ:PODD – Get Free Report) shares shot up 10.7% during trading on Friday after BTIG Research raised their price target on the stock from $260.00 to $270.00. BTIG Research currently ...

insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. Receive News & Ratings ...

His death was caused by diabetic ketoacidosis, a condition that develops when a person’s body does not have enough insulin for blood sugar to provide energy to its cells.

Then, last November, I had an unquenchable thirst. My mouth was so dry that I felt like a camel was going to traipse out of ...

US-based device company Luna Diabetes has initiated a pivotal trial evaluating its automated closed-loop insulin technology, ...

If NNC2215 were used clinically, it seems likely that individuals would also need to inject a rapid-acting insulin (which starts working in about 15 minutes) at mealtimes to avoid a large spike in ...

Patients on basal-bolus insulin therapy should check their blood glucose before each meal and figure this value into the calculation of the dose of rapid-acting insulin to take at that time.